partial lipodystrophy
partial lipodystrophy
Explore linked clinical trials. Standard reference: MONDO:00277674 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance | Insulin Resistance, Nutritional and Metabolic Diseases, acquired partial lipodystrophy, glucose metabolism disease, hyperinsulinism, metabolic disease, partial lipodystrophy | Recruiting | Phase 2 | 2026-08-18 | NCT05470504 | |
| MEASuRE: Metreleptin Effectiveness And Safety Registry | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Nutritional and Metabolic Diseases, Skin Diseases, Metabolic, Skin and Connective Tissue Diseases, acquired partial lipodystrophy, congenital generalized lipodystrophy, hereditary disease, inborn errors of metabolism, lipodystrophy, metabolic disease, partial lipodystrophy, skin disorder | Recruiting | Not stated | 2026-07-16 | NCT02325674 | |
| Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With PL | acquired partial lipodystrophy, partial lipodystrophy | Active, not recruiting | Phase 3 | 2026-06-15 | NCT05164341 | |
| Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy | acquired partial lipodystrophy, partial lipodystrophy | Recruiting | Phase 4 | 2025-07-03 | NCT06484868 |